Mesothelioma
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 21, 2016 Category: Journals (General) Source Type: news

South Korea Tightens Asbestos Regulations
South Korea is strengthening its Asbestos Safety Management Act (ASMA) beginning next month to better protect those involved in the renovation or demolition of older structures. The country has added to the recent, worldwide momentum aimed at minimizing health risks stemming from exposure to asbestos. South Korea already is one of 58 countries that have banned the toxic mineral, joining that club in 2009. New Zealand became the latest country to ban asbestos in June. Canadian Prime Minister Justin Trudeau in May announced his intention to work toward a ban. The United States earlier this year amended its Toxic Substances ...
Source: Asbestos and Mesothelioma News - July 20, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos ban asbestos ban in canada asbestos ban in united states asbestos regulations mesothelioma south korea asbestos Source Type: news

Panel Recommends Expanded Mesothelioma Drug Regimen, According to...
A 27-member national network of cancer centers says mesothelioma care could be improved by adding a third drug to standard mesothelioma chemotherapy.(PRWeb July 16, 2016)Read the full story at http://www.prweb.com/releases/2016/07/prweb13557826.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 16, 2016 Category: Pharmaceuticals Source Type: news

IMPRINT Mesothelioma Treatment Boosts Radiation Therapy
Doctors confirmed a novel radiation procedure can be combined safely and effectively with aggressive lung-sparing surgery to improve survival time and quality of life for patients with mesothelioma. After a decade of refinement, a small number of mesothelioma specialty centers now are using intensity-modulated pleural radiation therapy (IMPRINT) as part of the recent advancements in multidisciplinary treatments. “We’re hoping that all centers with experience in treating mesothelioma will now look at this as another technique to put in their arsenal,” radiation oncologist Dr. Kenneth Rosenzweig of the Moun...
Source: Asbestos and Mesothelioma News - July 15, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: cancer treatments IMPRINT for mesothelioma lung cancer treatments mesothelioma treatment pleural mesothelioma radiation for mesothelioma radiation therapy Source Type: news

IMPRINT Mesothelioma Treatment Boosts Radiation Therapy
Doctors confirmed a novel radiation procedure can be combined safely and effectively with aggressive lung-sparing surgery to improve survival time and quality of life for patients with mesothelioma. After a decade of refinement, a small number of mesothelioma specialty centers now are using intensity-modulated pleural radiation therapy (IMPRINT) as part of the recent advancements in multidisciplinary treatments. “We’re hoping that all centers with experience in treating mesothelioma will now look at this as another technique to put in their arsenal,” radiation oncologist Dr. Kenneth Rosenzweig of the Moun...
Source: Asbestos and Mesothelioma News - July 15, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: cancer treatments IMPRINT for mesothelioma lung cancer treatments mesothelioma treatment pleural mesothelioma radiation for mesothelioma radiation therapy Source Type: news

New Research Finds Protein Could Be Target for Novel Mesothelioma...
Italian scientists say blocking a protein produced by the P2X7R gene has the potential to stop mesothelioma in its tracks.(PRWeb July 14, 2016)Read the full story at http://www.prweb.com/releases/2016/07/prweb13549629.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 15, 2016 Category: Pharmaceuticals Source Type: news

ONCOS-102 Mesothelioma Clinical Trial Promises Hope
Scandinavian-based Targovax launched the latest immunotherapy clinical trial for pleural mesothelioma, hoping it delivers a better way to treat patients with asbestos-related diseases. The randomized phase Ib/II trial evaluates the performance of ONCOS-102, an engineered human adenovirus designed to induce systemic, anti-tumor responses. Researchers are administering the immunotherapy drug as first-line therapy in combination with chemotherapy using pemetrexed and cisplatin. “Based on what we’ve seen in our first study of patients with various solid tumor types, which is good tolerance and response in a couple ...
Source: Asbestos and Mesothelioma News - July 12, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: immunotherapy clinical trial immunotherapy for cancer mesothelioma mesothelioma clinical trials mesothelioma immunotherapy ONCOS 102 Source Type: news

Prophylactic Radiotherapy to Intervention Sites in MesotheliomaProphylactic Radiotherapy to Intervention Sites in Mesothelioma
Prophylactic radiotherapy to intervention sites in mesothelioma does not significantly reduce procedure-tract metastases (PTMs), according to a randomized trial in 22 UK hospitals. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 11, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Mesothelioma Awareness Is About People, Not Payments
I get the same reaction from almost everyone when I tell them what type of cancer I battled. The conversation usually goes something like this: Them: What type of cancer did you have? Me: I was diagnosed with a relatively unknown cancer called mesothelioma Them: (blank look) I've never heard of that! Me: Most people haven't. It's pretty rare. Them: (the light comes on) Wait a minute! Isn't that the cancer those TV commercials are about? Me: (nodding, and anticipating all the questions to come) Them: Ohh, YOU were exposed to asbestos? I thought that stuff was banned? Did you sue?? Did you get a lot of money? Me: (d...
Source: Healthy Living - The Huffington Post - July 8, 2016 Category: Consumer Health News Source Type: news

Researchers Discover New Mesothelioma Blood Biomarker
An international team of scientists recently identified a new blood biomarker for mesothelioma that should help with early diagnosis, prognosis accuracy and the personalization of treatment. Researchers identified activin A, a protein complex found in the blood, as a potential target for future therapies. “Blood derived biomarkers are important because they can be noninvasively measured, even at multiple stages,” Dr. Balazs Hegedus, at the Medical University of Vienna in Austria, told Asbestos.com. “They can help make the best personalized therapeutic decisions.” In addition to Hegedus, cancer speci...
Source: Asbestos and Mesothelioma News - July 7, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: activin A asbestos cancer asbestos diseases Balazs Hegedus cancer treatment mesothelioma mesothelioma biomarker mesothelioma blood biomarker mesothelioma research multimodal cancer therapy treatments for mesothelioma Source Type: news

Targovax doses first patient in Phase Ib/II trial of ONCOS-102 to treat MPM
Norwegian-based immuno-oncology company Targovax has dosed the first patient in the Phase Ib/II combination trial of a combination pemetrexed and cisplatin with ONCOS-102 to treat malignant pleural mesothelioma (MPM). (Source: Drug Development Technology)
Source: Drug Development Technology - July 4, 2016 Category: Pharmaceuticals Source Type: news

Expected Federal Decision on Cannabis Could Impact Mesothelioma...
Malignant mesothelioma patients who want to incorporate medical marijuana into their treatment regimen should know about this impending DEA ruling.(PRWeb July 01, 2016)Read the full story at http://www.prweb.com/releases/2016/07/prweb13525182.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 2, 2016 Category: Pharmaceuticals Source Type: news

New Study: Asbestos Related to Most Common Kidney Cancer
Exposure to asbestos may lead to renal cell carcinoma, the most common type of kidney cancer, an Italian study shows. The link to kidney cancer adds to the horrific history of asbestos, a substance definitively recognized as a cause of mesothelioma, lung cancer and a variety of other respiratory illnesses. In the past, a handful of other cancers were inconclusively linked to asbestos exposure. However, the research team at the University of Pavia in Italy made its case for asbestos as a probable cause of renal cell carcinoma. “The findings did surprise me. It was something I had not suspected before,” Stefano C...
Source: Asbestos and Mesothelioma News - July 1, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos cancer asbestos related to kidney cancer cancer research mesothelioma peritoneal mesothelioma Source Type: news

Asbestos-Related Cancers Cost Canada $2B Annually
The Canadian government spends about $1.7 billion annually on asbestos-related cancers stemming from occupational exposure, according to a recent Institute for Work & Health study. Researchers included the costs of treating mesothelioma and asbestos-related lung cancer, administration expenses, patients’ out-of-pocket costs, caregiving wages, workers’ compensation and employers’ costs to replace absent workers, among other economic burdens. The investigation did not include cancers from secondhand exposure to asbestos and other cancers caused by asbestos exposure. “This [number] is really just t...
Source: Asbestos and Mesothelioma News - June 29, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos cancer asbestos in canada asbestos in canada construction asbestos in canada homes asbestos related cancers canadian asbestos epidemic mesothelioma work related asbestos exposure Source Type: news

New Study Finds Activin A May be a Novel Mesothelioma Biomarker,...
Researchers from cancer centers across Europe and Australia have recently discovered that this protein complex can reveal vital information about the asbestos cancer.(PRWeb June 27, 2016)Read the full story at http://www.prweb.com/releases/2016/06/prweb13483734.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 27, 2016 Category: Pharmaceuticals Source Type: news

New Zealand Enacts National Asbestos Ban
New Zealand will prohibit importation of all asbestos products and materials beginning Oct. 1, joining 57 other countries that already ban asbestos. Nick Smith, New Zealand environment minister, announced the latest prohibition last week. His statement marked progress toward a long-sought, worldwide ban on the toxic mineral. “It’s about bloody time,” Laurie Kazan-Allen, coordinator of the International Ban Asbestos Secretariat, told Asbestos.com. Kazan-Allen, who is based in the United Kingdom, is one of the world’s foremost authorities on the global asbestos watch. “We’re in an interest...
Source: Asbestos and Mesothelioma News - June 23, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos ban asbestos cancer asbestos mesothelioma banning asbestos national ban on asbestos new zealand asbestos ban Source Type: news

Immunotherapy Trial for Mesothelioma Shows Early Promise
The immunotherapy drug avelumab showed promising results in a recent phase I clinical trial for malignant mesothelioma, raising hopes as a future second-line therapy. The clinical trial included 53 patients with pleural or peritoneal mesothelioma. It was part of the JAVELIN development program for avelumab, a series of clinical studies testing the drug on about 2,200 patients with more than 15 types of cancer. Merck and Pfizer are co-developing and marketing avelumab. Medical oncologist and mesothelioma specialist Dr. Raffit Hassan of the National Cancer Institute (NCI) presented the clinical trial results earlier this mon...
Source: Asbestos and Mesothelioma News - June 22, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: clinical trial immunotherapy immunotherapy clinical trial immunotherapy for mesothelioma mesothelioma research mesothelioma treatment raffitt hassan Source Type: news

New Findings Support Synergistic Effect of New Mesothelioma...
An anti-cancer drug made of an altered virus appears to boost the effectiveness of standard mesothelioma chemotherapy.(PRWeb June 17, 2016)Read the full story at http://www.prweb.com/releases/2016/06/prweb13492055.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 17, 2016 Category: Pharmaceuticals Source Type: news

Mesothelioma Surgery Improves Quality of Life
Renowned thoracic surgeon Dr. Wickii Vigneswaran in Chicago believes far too many patients with pleural mesothelioma are being denied aggressive surgeries that could improve their quality of life. He wants to fix that dilemma. Vigneswaran, a mesothelioma specialist at the Loyola University Medical Center, authored a recent study debunking the long-standing belief that major surgery is too taxing for all but the healthiest patients. “It’s the medical community, the referring physicians, even the oncologists, who are telling patients that surgery is not an option for them, that it will hurt their quality of life,...
Source: Asbestos and Mesothelioma News - June 17, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: cancer surgery cancer treatment mesothelioma mesothelioma surgery mesothelioma treatment Wickii Vigneswaran Source Type: news

Scientists Say Overexpressed Enzyme May be Key to More Effective...
Mesothelioma patients whose tumors overexpress a particular enzyme may be more likely to respond to treatment with a drug called S-1.(PRWeb June 12, 2016)Read the full story at http://www.prweb.com/releases/2016/06/prweb13481246.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 13, 2016 Category: Pharmaceuticals Source Type: news

Researchers Report Positive Response in Mesothelioma Patients on...
Doctors leading a Phase I study of a potential new drug for mesothelioma say the preliminary results look promising.(PRWeb June 10, 2016)Read the full story at http://www.prweb.com/releases/2016/06/prweb13475771.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 10, 2016 Category: Pharmaceuticals Source Type: news

Asbestos Ban in US Inches Closer with New Legislation
Federal lawmakers this week passed one of the most important environmental bills that will overhaul how the U.S. government regulates toxic chemicals, and it could bring the nation closer to banning asbestos. The U.S. Senate passed the Frank R. Lautenberg Chemical Safety for the 21st Century Act, which amends the Toxic Substances Control Act (TSCA) of 1979. The bill will give the U.S. Environmental Protection Agency (EPA) greater power to better review chemicals for safety and restrict their use. One of the reasons asbestos is not banned in the U.S. is because the current law requires the EPA to find the “least burde...
Source: Asbestos and Mesothelioma News - June 10, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos asbestos ban asbestos exposure banning asbestos in the united states Frank R. Lautenberg Chemical Safety for the 21st Century Act united states asbestos ban Source Type: news

Mesothelioma surgery improves quality of life, study finds
Many mesothelioma patients avoid surgery for fear it will degrade their quality of life. But a study has found just the opposite: Patients who underwent an operation called pleurectomy and decortication (PD) generally reported their quality of life improved after surgery. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 9, 2016 Category: Science Source Type: news

Mesothelioma surgery improves quality of life, study finds
(Loyola University Health System) Many mesothelioma patients avoid surgery for fear it will degrade their quality of life. But a study has found just the opposite: Patients who underwent an operation called pleurectomy and decortication (PD) generally reported their quality of life improved after surgery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 8, 2016 Category: Global & Universal Source Type: news

Canadian Doctors Test Pemetrexed in Mesothelioma HIPEC Treatment,...
Researchers say the mesothelioma drug has potential for use in heated chemotherapy technique.(PRWeb June 04, 2016)Read the full story at http://www.prweb.com/releases/2016/06/prweb13461333.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 4, 2016 Category: Pharmaceuticals Source Type: news

Quincy Jones Talks Mesothelioma in HBO’s ‘Burning the Light’
Last night, comedian Quincy Jones opened his heart to HBO viewers with “Quincy Jones: Burning the Light,” a one-hour special about his personal battle with mesothelioma. “There is no cancer when I am on that stage,” the 31-year-old told the audience at the Teragram Ballroom in Los Angeles. “It is only me telling my jokes. You can deal with the cancer before and you can deal with it after. But on that stage, I’m cancer-free.” After months of raising awareness about mesothelioma, Jones’s dream finally came true with a giant thank you to “The Ellen DeGeneres Show,” ...
Source: Asbestos and Mesothelioma News - June 3, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: comedian quincy jones HBO hbo special burning the light mesothelioma Source Type: news

Peritoneal Mesothelioma: No End in Sight
Conclusions Among the conclusions from the review: All types of asbestos — including amphibole and chrysotile — can cause peritoneal mesothelioma. Men and women have the same vulnerability to asbestos exposure, from either occupational or second-hand exposures. There is no safe level of asbestos exposure that can prevent peritoneal mesothelioma. Doctors have dramatically underreported peritoneal mesothelioma because misdiagnosis is common. “There were no real surprises [in the findings], but people have started to believe some of the misconceptions, and even some of the so-called experts were confused,&...
Source: Asbestos and Mesothelioma News - May 31, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: mesothelioma mesothelioma surgery mesothelioma treatment new mesothelioma study peritoneal mesothelioma treatment for peritoneal mesothelioma Source Type: news

Mesothelioma Study: Age Is Not Deciding Factor for Surgery
A recent study has reinforced — for the second time — the growing belief that age should not be a deterrent to aggressive, life-changing surgery for malignant pleural mesothelioma. You’re never too old. Dr. Annabel Sharkey, cardiothoracic surgeon at the University of Leicester in the United Kingdom, said patients well over the age of 70 can be as successful with extended pleurectomy/decortication (P/D) surgery as those who are considerably younger. “We should not be using age to decide who will benefit from surgery,” Sharkey told Asbestos.com. “In the past, people sometimes thought they ...
Source: Asbestos and Mesothelioma News - May 27, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: latest mesothelioma research mesothelioma surgery new mesothelioma study Source Type: news

Study Finds Too Many Options Make Second Line Mesothelioma Treatment...
Researchers in Greece say having a diversity of second line treatment choices is not necessarily good news for mesothelioma patients.(PRWeb May 25, 2016)Read the full story at http://www.prweb.com/releases/2016/05/prweb13441324.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 25, 2016 Category: Pharmaceuticals Source Type: news

Scientists Say Antibiotic Triggers Mesothelioma Cell Death, According...
Evidence suggests that an antibiotic derived from the Streptomyces bacterium may help in the fight against the intractable asbestos cancer.(PRWeb May 20, 2016)Read the full story at http://www.prweb.com/releases/2016/05/prweb13428175.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 20, 2016 Category: Pharmaceuticals Source Type: news

Comedian Quincy Jones Plans To 'Burn The Light' On Cancer With HBO Special
Comedian Quincy Jones is living proof that dreams really do come true, no matter the circumstance. The 32-year-old comic will premiere his HBO comedy special “Burning The Light,” on June 2. Initially launched as a Kickstarter initiative, Jones' campaign to launch the comedy show went viral following his March appearance on “The Ellen DeGeneres Show.” He discussed his diagnosis with Stage 4 mesothelioma cancer and outlined his mission to raise money to film a comedy special while on the daytime television program. A week following his appearance, on March 21, Jones returned to "Ellen" where...
Source: Healthy Living - The Huffington Post - May 19, 2016 Category: Consumer Health News Source Type: news

Canada’s Prime Minister Trudeau Commits to Ban Asbestos
Canadian Prime Minister Justin Trudeau recently announced what labor and public health groups have spent years waiting to hear about the nation’s asbestos epidemic. “We’ve actually made the commitment that we are moving forward on a ban,” Trudeau said. “We know that its impact on workers far outweighs any benefits that it might provide.” Trudeau made the comment in response to a trade union leader’s question while speaking at Canada’s Building Trades Union policy conference in Ottawa, according to the Canadian Broadcasting Corporation (CBC) news agency. While the country no l...
Source: Asbestos and Mesothelioma News - May 19, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos deaths in canada asbestos exposure in canada canada asbestos ban justin trudeau asbestos ban Source Type: news

Canada's Prime Minister Trudeau Commits to Ban Asbestos
Canadian Prime Minister Justin Trudeau recently announced what labor and public health groups have spent years waiting to hear about the nation's asbestos epidemic. “We’ve actually made the commitment that we are moving forward on a ban," Trudeau said. "We know that its impact on workers far outweighs any benefits that it might provide.” Trudeau made the comment in response to a trade union leader's question while speaking at Canada’s Building Trades Union policy conference in Ottawa, according to the Canadian Broadcasting Corporation (CBC) news agency. While the country no longer...
Source: Asbestos and Mesothelioma News - May 19, 2016 Category: Environmental Health Authors: Beth Swantek Tags: Legislation, Laws & Litigation Source Type: news

Why Do Women with Mesothelioma Survive Longer than Men?
A recent study from Brigham and Women's Hospital in Boston has pinpointed for the first time gender-specific genetic mutations in mesothelioma patients that could lead to future treatment advances. Women with mesothelioma typically have a survival advantage over men with the same disease, as numerous studies have currently shown. But now, scientists are beginning to understand why that advantage exists, and how it could lead to more effective treatment for everyone. "We were trying to identify genetic differences to help provide targets for specific therapies," Dr. Assunta De Rienzo, co-director of the ...
Source: Asbestos and Mesothelioma News - May 11, 2016 Category: Environmental Health Authors: Tim Povtak Tags: Research & Clinical Trials Source Type: news

Mr. Fluffy Asbestos: Photos Educate Canberra Homeowners
New photos of loose asbestos in a Mr. Fluffy home in Canberra show an extreme example of the contamination that has endangered residents in Australia's capital city for decades. The Australian Capital Territory (ACT) government's Asbestos Response Taskforce took the pictures inside one of the 1,022 Canberra homes known to contain Mr. Fluffy insulation. Thousands of homes were insulated with Mr. Fluffy-brand asbestos in the 1960s and '70s. Breathing the insulation can cause the rare cancer mesothelioma, which develops 20 to 50 years after asbestos exposure. “What we found inside the walls was a very signific...
Source: Asbestos and Mesothelioma News - May 5, 2016 Category: Environmental Health Authors: Beth Swantek Tags: Asbestos Exposure & Bans Source Type: news

Asbestos Fears Linger After Massive Australian Brush Fire
Nearly five months after a catastrophic brush fire devastated the historic timber town of Yarloop in Western Australia, residents may now be at risk of asbestos exposure. The blaze damaged much of the asbestos previously hidden inside the town's renovated structures, and that could have long-lasting effects on Yarloop. Containing the asbestos may impede cleanup efforts, and it's unclear how much residents were exposed to the carcinogen known to cause deadly mesothelioma. However, Dr. Andy Robertson, director of disaster management at the WA Department of Health, said asbestos levels in Yarloop shouldn't be high. ...
Source: Asbestos and Mesothelioma News - May 4, 2016 Category: Environmental Health Authors: Lorraine Kember Tags: Asbestos Exposure & Bans Source Type: news

Immunotherapy Vaccine for Mesothelioma Gets High Marks
Immunotherapy vaccine CRS-207 is moving closer to changing the way malignant pleural mesothelioma will be treated in the future. CRS-207 produced a startling 94 percent disease control rate when combined with a chemotherapy cocktail of cisplatin and pemetrexed in a recent, multicenter clinical trial. Thoracic oncologist Dr. Thierry Jahan of the UCSF Helen Diller Family Comprehensive Cancer Center detailed the results last week at the 2016 European Lung Cancer Conference. “We’ve seen a really impressive response,” Jahan said. “It’s an impressive signal for a study like this.” ...
Source: Asbestos and Mesothelioma News - May 3, 2016 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

Asbestos Scandal in UK Schools Blamed on Government
Sarah Jane Bowman lives with a death sentence. At age 40, the U.K. native received tragic news that she had the deadly cancer mesothelioma. “To be told that I had a terminal illness and had less than a year to live was simply too much to comprehend,” Bowman said in a report issued by the Joint Union Asbestos Committee (JUAC). “My family and I have struggled to overcome this.” Mesothelioma is a rare disease with a long latency period that affects mostly tradesman, such as pipefitters and contractors, in the latter years of their lives. For them, exposure to toxic asbestos is an occupational hazard. B...
Source: Asbestos and Mesothelioma News - April 26, 2016 Category: Environmental Health Authors: dev Source Type: news

Asbestos Scandal in UK Schools Blamed on Government
Sarah Jane Bowman lives with a death sentence. At age 40, the U.K. native received tragic news that she had the deadly cancer mesothelioma. “To be told that I had a terminal illness and had less than a year to live was simply too much to comprehend,” Bowman said in a report issued by the Joint Union Asbestos Committee (JUAC). “My family and I have struggled to overcome this.” Mesothelioma is a rare disease with a long latency period that affects mostly tradesman, such as pipefitters and contractors, in the latter years of their lives. For them, exposure to toxic asbestos is an occupational ...
Source: Asbestos and Mesothelioma News - April 26, 2016 Category: Environmental Health Authors: Beth Swantek Tags: Asbestos Exposure & Bans Source Type: news

Cancer Researchers Say Iron Elimination May Help Prevent Development...
Japanese scientists find that removing iron from the system of asbestos-exposed rats reduced the changes that can lead to mesothelioma.(PRWeb April 22, 2016)Read the full story at http://www.prweb.com/releases/2016/04/prweb13362032.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 22, 2016 Category: Pharmaceuticals Source Type: news

Bacterial Product Boosts Mesothelioma Chemotherapy ResponseBacterial Product Boosts Mesothelioma Chemotherapy Response
Response rates to chemotherapy among patients with mesothelioma are substantially increased by adding a live, attenuated bacterium expressing a tumor-associated antigen, US trial results indicate. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 21, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

NYU's Perlmutter Cancer Center & the Technion launch global cancer research initiative
(NYU Langone Medical Center / New York University School of Medicine) Drug-carrying 'nanoghosts' that battle melanoma and new treatments for malignant mesothelioma will be the focus of the first joint research projects led by NYU Langone Medical Center and the Technion-Israel Institute of Technology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 21, 2016 Category: Cancer & Oncology Source Type: news

Surviving Mesothelioma Talks with Six-Year Mesothelioma Survivor Who...
Six years after receiving a diagnosis of deadly malignant pleural mesothelioma and being given less than a year to live, Andy Ashcraft is alive and well.(PRWeb April 20, 2016)Read the full story at http://www.prweb.com/releases/2016/04/prweb13352025.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 20, 2016 Category: Pharmaceuticals Source Type: news

Univ. of Hawaii Awarded $3M Mesothelioma Research Grants
The U.S. Department of Defense (DOD) awarded three grants totaling more than $3 million to researchers at the University of Hawaii Cancer Center last month to advance their studies of mesothelioma. The awards were part of the Peer Reviewed Cancer Research Program funded by the DOD. The University of Hawaii has been a national leader in the study of mesothelioma, which strikes a disproportionate number of military veterans. “We’re grateful that all the work we’ve put into research in the past is being recognized and appreciated,” Dr. Michele Carbone, director of thoracic oncology at the cancer center...
Source: Asbestos and Mesothelioma News - April 19, 2016 Category: Environmental Health Authors: dev Source Type: news